How 3 psychedelics firms got into a coveted Y Combinator program

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Health Health Headlines News

The famed startup accelerator Y Combinator is wading into the $100 billion psychedelics industry. Here's how 3 psychedelics firms got into the program.

Osmind CEO Lucia Huang told Insider that Y Combinator places a big focus on the teams leading each startup.She added that there's also a big focus on the team and whether your specific team is composed of the top people in the world to work on the specific problem outlined.says that over 10,000 companies apply to its programs

Dillan DiNardo, cofounder and CEO of the summer 2021 cohort Mindstate Design Labs, said that he presented a unique approach to psychedelics-assisted therapy that other companies weren't exploring at the time. Sporn has an extensive background in neuroscience at companies like Pfizer and Perception Neuroscience . He and his team weren't the 20-somethings who typically participated. Gilgamesh was a part of Y Combinator's summer 2020 cohort.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

著名的创业加速器Y Combinator正在涉足价值1000亿美元的迷幻药行业。下面是3家迷幻药公司如何加入该计划的。

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in HEALTH

Health Health Latest News, Health Health Headlines